Sunshine Biopharma, Inc. (SBFM)

Sunshine Biopharma Revenue

Sunshine Biopharma had revenue of $9.41M in the quarter ending June 30, 2025, with 1.15% growth. This brings the company's revenue in the last twelve months to $36.34M, up 19.22% year-over-year. In the year 2024, Sunshine Biopharma had annual revenue of $34.87M with 44.75% growth.

• Revenue (ttm): $36.34M
• Revenue Growth: +19.22%
• P/S Ratio: 0.13
• Revenue / Employee: $698,880
• Employees: 52
• Market Cap: 8.70M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	34.87M	10.78M	44.75%
Dec 31, 2023	24.09M	19.75M	454.42%
Dec 31, 2022	4.35M	4.12M	1,802.41%
Dec 31, 2021	228.43K	157.02K	219.88%
Dec 31, 2020	71.41K	50.29K	238.10%